Bacchus Vascular Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Bacchus Vascular General Information

Description

Developer of medical devices and provides treatments for peripheral vascular disease. The company develops procedure to percutaneously remove blood clots from dialysis and peripheral grafts as well as native arteries and veins.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3110 Coronado Drive
  • Santa Clara, CA 95054
  • United States
+1 (408) 000-0000
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Acquirer
Corporate Office
  • 3110 Coronado Drive
  • Santa Clara, CA 95054
  • United States
+1 (408) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bacchus Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 06-Mar-2009 000.00 Completed Generating Revenue
7. Later Stage VC 13-Feb-2008 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series A1) 17-Dec-2007 00.00 000.00 000.00 Completed Product Development
5. Later Stage VC (Series A1) 19-Oct-2007 000.00 000.00 000.00 Completed Product Development
4. Later Stage VC (Series D) 09-Jul-2003 0000 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series C) 15-Nov-2001 00.000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 03-May-2000 $7.18M $8.39M 0000 Completed Startup
1. Early Stage VC (Series A) 26-May-1999 $1.22M $1.22M 00.000 Completed Startup
To view Bacchus Vascular’s complete valuation and funding history, request access »

Bacchus Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Bacchus Vascular’s complete cap table history, request access »

Bacchus Vascular Patents

Bacchus Vascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003286518-A1 Apparatus and methods for clot dissolution Inactive 21-Oct-2002 0000000000000
AU-2003286518-A8 Apparatus and methods for clot dissolution Inactive 21-Oct-2002 0000000000000
AU-2003234601-A1 Apparatus and method for removing occlusive material within blood vessels Inactive 14-May-2002 00000000000
AU-2003234601-A8 Apparatus and method for removing occlusive material within blood vessels Inactive 14-May-2002 00000000000
AU-2002308583-A1 Apparatus and methods for capturing particulate material within blood vessels Inactive 21-May-2001 A61B17/22
To view Bacchus Vascular’s complete patent history, request access »

Bacchus Vascular Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atherton Venture Partners Venture Capital Minority 000 0000 000000 0
De Novo Ventures Venture Capital Minority 000 0000 000000 0
Frantz Medical Ventures Corporate Venture Capital Minority 000 0000 000000 0
Kaiser Permanente Ventures Corporate Venture Capital Minority 000 0000 000000 0
Saratoga Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Bacchus Vascular FAQs

  • When was Bacchus Vascular founded?

    Bacchus Vascular was founded in 1999.

  • Where is Bacchus Vascular headquartered?

    Bacchus Vascular is headquartered in Santa Clara, CA.

  • What industry is Bacchus Vascular in?

    Bacchus Vascular’s primary industry is Medical Supplies.

  • Is Bacchus Vascular a private or public company?

    Bacchus Vascular is a Private company.

  • What is Bacchus Vascular’s current revenue?

    The current revenue for Bacchus Vascular is 000000.

  • How much funding has Bacchus Vascular raised over time?

    Bacchus Vascular has raised $80.3M.

  • Who are Bacchus Vascular’s investors?

    Atherton Venture Partners, De Novo Ventures, Frantz Medical Ventures, Kaiser Permanente Ventures, and Saratoga Ventures are 5 of 8 investors who have invested in Bacchus Vascular.

  • When was Bacchus Vascular acquired?

    Bacchus Vascular was acquired on 06-Mar-2009.

  • Who acquired Bacchus Vascular?

    Bacchus Vascular was acquired by Covidien.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »